IM Cannabis Corp. current report, Q3 FY2026

IM Cannabis Corp. Form 6-K Summary

Business context and reporting period

IM Cannabis Corp., an Israeli foreign private issuer, furnished this Form 6-K on September 23, 2026, for the month of September 2026 (Report No. 2). The filing reports the issuance of a press release concerning a proposed strategic transaction.

Transaction and key financial information

The Company announced a non-binding agreement to acquire a 51% interest in Space Defense Innovations, which operates in the European tactical unmanned aerial systems market.

The filing text does not provide the proposed purchase price, financing terms, valuation, expected closing date, operating results of Space Defense Innovations, or any forecast financial contribution.

No revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics are reported in this filing.

Material changes versus the prior comparable period

The filing does not present comparative financial information or quantify changes from a prior period. The proposed acquisition represents a potential expansion beyond the Company’s existing cannabis-related business, but the filing does not provide additional operating or financial details.

Guidance, outlook, risks, contingencies, and unusual items

  • The agreement is expressly non-binding and may not result in a completed acquisition.
  • Completion terms, conditions, required approvals, due diligence, financing, and other closing contingencies are not described in the Form 6-K text.
  • The filing does not provide management guidance or a quantified outlook.
  • The filing does not describe transaction-related risks, integration plans, or the strategic rationale beyond identifying Space Defense Innovations’ European tactical UAS operations.

Important facts for investors to verify

  • Whether a definitive agreement is executed and the conditions required to close.
  • The purchase price, funding source, ownership structure, and potential dilution.
  • Space Defense Innovations’ financial condition, operating performance, backlog, and regulatory environment.
  • Any subsequent filings or announcements that provide transaction terms, approvals, closing status, or updated guidance.
  • The impact of the proposed transaction on IM Cannabis Corp.’s core cannabis operations and liquidity.